Antithrombin deficiency: Difference between revisions
Jump to navigation
Jump to search
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
m Bot: Adding CME Category::Cardiology |
||
Line 37: | Line 37: | ||
{{Hematology}} | {{Hematology}} | ||
[[pt:Deficiência de antitrombina III]] | [[pt:Deficiência de antitrombina III]] | ||
Line 45: | Line 42: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[CME Category::Cardiology]] | |||
[[Category:Hematology]] | |||
[[Category:Cardiology]] |
Revision as of 21:38, 14 March 2016
Antithrombin deficiency | |
ICD-9 | 289.81 |
---|---|
OMIM | 107300 |
DiseasesDB | 783 |
eMedicine | ped/119 |
MeSH | D020152 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Antithrombin III deficiency is a rare hereditary disorder that generally comes to light when a patient suffers recurrent venous thrombosis and pulmonary embolism.
This was first described by Egeberg in 1965.[1]
The patients are treated with anticoagulants or, more rarely, with antithrombin concentrate.
In renal failure, especially nephrotic syndrome, antithrombin is lost in the urine, leading to a higher activity of Factor II and Factor X and in increased tendency to thrombosis.
See also
References
- ↑ Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965;13:516–520. PMID 14347873.